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The gut is home to our largest collection of microbes. The ability of the immune system to coevolve
with the microbiota during postnatal life allows the host and microbiota to coexist in a mutually
beneficial relationship. Failure to achieve or maintain equilibrium between a host and its microbiota
has negative consequences for both intestinal and systemic health. In this Review, we consider the
many cellular and molecular methods by which inflammatory responses are regulated to maintain
intestinal homeostasis and the disease states that can ensue when this balance is lost.Introduction
Immunology has been defined as the ‘‘science of self non-self
discrimination’’ (Klein, 1999) with the assumption that ‘‘non-
self’’ intrusions instigate the inflammatory response. However,
the very definition of self requires further examination when we
consider that we harbor microbial communities (microbiota)
that contain an estimated order of magnitude more cells than
our own somatic and germ cells. These communities exhibit
a remarkable degree of variation within and between individuals
(Grice et al., 2009; Turnbaugh et al., 2009a) and provide us with
traits that we have not had to evolve on our own (Turnbaugh
et al., 2007). The application of culture-independent metage-
nomic methods has shed light on the organismal and genetic
composition, as well as dynamic operations, of the microbial
communities that integrate themselves into our various body
habitats (see Hamady and Knight, 2009, for a review of the
experimental and computational methods used for metage-
nomic analyses). These communities can harbor representatives
from all three branches of life (Bacteria, Archaea, and Eukarya)
and their viruses. Many fundamental questions arise when
considering this microbial component of our multispecies
‘‘self’’: how has the immune system been shaped by the need
to accommodate our symbionts, how does it coevolve with
a microbiota to both shape and accommodate community
assembly, how does the immune system drive and tolerate the
variations in microbial ecology that occur within a host’s given
body habitat over time, to what extent does the continuous
evolution of various microbial phylogenetic types (phylotypes)
underlie this apparent tolerance, and how do the adaptive and
innate immune systems retain the capacity to respond to patho-
genic organisms?
The intestine represents a body habitat that vividly illustrates
these issues. The distal gut of humans represents one of the
most densely populated microbial ecosystems on Earth, with
up to 1012 organisms packed together per milliliter or gram of
luminal contents. This ecosystem is dominated by members of
the Bacteria: among the 100 known phyla in this domain of life,members of the Firmicutes and the Bacteroidetes form the
largest component of the distal gut community (Ley et al.,
2008). Although the total number of phyla detected to date in
the human gut is relatively low compared to other natural envi-
ronments such as soil or the ocean, diversity at the level of
species and strains is enormous. Ametagenomic study of bacte-
rial diversity in fecal samples obtained from adult monozygotic
and dizygotic twin pairs and their mothers over time have
revealed that (1) the communities with the greatest degree of
similarity were those derived from the same individual, (2) the
degree of similarity in the gut bacterial communities of monozy-
gotic twin pairs was not significantly different than the similarity
between dizygotic twin pairs, (3) communities are more similar
within family members than between different families (i.e.,
family members share significantly more phylotypes than unre-
lated individuals), and (4) there was not a single abundant
(defined as representing >0.5% of the population) bacterial
species present in all of the 154 individuals surveyed. These
results emphasize that early environmental exposures are
a key determinant of adult gut microbial ecology and that the
hypothesis that there is a ‘‘core’’ gutmicrobiota defined by abun-
dant organismal lineages shared by all humans is likely incorrect.
Shotgun sequencing of the aggregate genome (microbiome) of
the fecal communities of different families revealed that different
microbial communities (species assemblages) converge on the
same functional state: i.e., there is a group of microbial genes
represented in the guts of unrelated as well as related individ-
uals. This ‘‘core’’ microbiome is enriched in functions related to
survival in the gut (e.g., translation, nucleotide, carbohydrate,
and amino acid metabolism). Genes whose proportional repre-
sentation in gut communities vary among individuals comprise
a ‘‘variable’’ microbiome. Pairwise comparisons have shown
that family members have functionally more similar gut micro-
biomes than do unrelated individuals. Thus, intrafamilial and
subsequent intergenerational transmission of a gut microbiome
(over multiple generations) could shape the biological features
of humans within a kinship, contributing to differences in theCell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc. 859
Figure 1. The Gut Landscape: Maintaining Intestinal Homeostasis
The mucus layer, sitting atop the intestinal epithelium, is a key component of the mucosal barrier and also is both a source of nutrients and a microhabitat for
bacterial members of the microbiota. The epithelial crypt-villus axis differs between the small and large intestine. The populating enterocyte populations vary,
as well. M cells and Paneth cells are restricted to the small intestine. Intestinal immune cells that mediate tolerance-inducing responses and participate in
host defense localize to inductive and effector sites. These sites include Peyer’s patches (small intestine), lymphoid follicles, and colonic patches (large intestine),
as well as effector sites such as the epithelium and underlying lamina propria.structures and operations of their innate and adaptive immune
systems and, together with their H. sapiens genotypes, modu-
late/mediate their risks for immunopathologic states, as well as
other diseases.
A second reason why the gut is such an attractive system for
studying thecoevolution andcoadaptation of the immunesystem
and microbiota is our increasing appreciation of the reciprocal
nature of the regulation of the immune system and microbial
community structure. The hematopoietic-derived innate and
adaptive immune systems are traditionally regarded as the hard-
ware, software, andadministrators of the inflammatory response.
Intestinal immune cells localize to inductive sites (Peyer’s
patches,mesenteric lymphnodes, lymphoid follicles, andcolonic860 Cell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc.patches) and effector sites (the epithelium and underlying lamina
propria) (see Figures 1 and 2). Comparative studies of germ-free
mice and their microbe-laden conventionally raised counter-
parts, or of adult germ-freemice that have received gut microbial
communities from conventionally raised donors, have estab-
lished that the intestinal microbiota is a key contributor to the
proper structuring of these sites (Macpherson and Harris,
2004). Themicrobiota instructs immune cells, guides their proper
assembly, and as such contributes to the proper functioning of
immunologic inductive sites. Position within the mucosal barrier
and the status of the barrier (its inflammatory tone) in turn shape
thedevelopment and fatechoicesof immunecells (seeReviewby
D.R. Littman and A.Y. Rudensky on page 845 in this issue).Figure 2. Regulators of Host-Microbial
Interactions in the Gut
The commensal microbiota, intestinal epithelial
cells, and intestinal immune cells engage in
a complex crosstalk. Epithelial cells, M cells, and
dendritic cells (DCs) can directly sense and
sample the intestinal contents and communicate
information about the microbiota to other subsets
of immune cells. Toll-like receptors, expressed by
epithelial cells, M cells and DCs, and NOD-like
receptors, are classes of microbe-sensing mole-
cules. Cytokines, chemokines, and host and
microbial metabolites are keymolecular mediators
of intestinal homeostasis that influence responses
of both host and microbe.
There are numerous examples of how genetically manipulated
mice have revealed the role of these and other components of
the immune network in accommodating the gut microbiota.
Below, we highlight recent insights gleaned about these compo-
nents and their interactions. Disruption of this homeostasis likely
results not only in intestinal inflammatory diseases, like Crohn’s
disease and ulcerative colitis, but may also contribute to ‘‘auto-
immune’’ diseases at extraintestinal sites, such as asthma and
type 1 diabetes (T1D). We end by emphasizing how the union
of metagenomic methods and gnotobiotic humanized mouse
models (containing only known microorganisms) will be useful
for characterizing features of human gut communities and of
the immune networks that support the coevolved homeostasis
between the microbial and H. sapiens components of our multi-
species ‘‘supraorganismal’’ self.
The Mucosal Barrier and the Microbiota
The gut epithelium forms an essential element of the mucosal
barrier. All five of its lineages—goblet cell, Paneth cell, M cell,
enteroendocrine cell, and absorptive enterocyte—contribute to
barrier function. The gut epithelium undergoes rapid and
perpetual self-renewal: this renewal is fueled by multipotential
Lgr5-expressing stem cells located in the crypts of Lieberkuhn
(Sato et al., 2009) and concludes with apoptosis/exfoliation of
terminally differentiated cells at the tips of small intestinal villi
or the villus homolog in the colon (the surface epithelial cuff).
Remarkably, this process of continuous epithelial replacement
occurs without disrupting the functional integrity of cell-cell junc-
tions. Regulation of junctional integrity and paracellular perme-
ability is especially important for immune system homeostasis
as a vast diversity of microbes and food antigens hover on the
luminal surface of the mucosal barrier. Pathogenic viruses,
bacteria, and parasites all exploit opportunities for breaching
the epithelial barrier by entering through junctions (Bergelson,
2009; O’Hara and Buret, 2008). Coxsackie B and adenovirus
bind to a receptor (CAR) that colocalizes with the tight junction
protein ZO-1 (Raschperger et al., 2006). Reoviruses exploit junc-
tional proteins for entry and their spread relies on binding to
JAM-A (Antar et al., 2009). Rotaviruses alter occludin localization
to tight junctions by changing the levels of nonphosphorylated
occludin (Beau et al., 2007). Enteropathogens, including Shigella
flexneri, Clostridium difficile, and Salmonella typhimurium alter
barrier function through secreted toxins or type III secretion
effectors that target junctional proteins or the junction-associ-
ated cytoskeleton.
Inflammatory mediators can modulate epithelial renewal to
promote host defense. IL-13, a proinflammatory cytokine, and
CXCL10, a chemokine, accelerate turnover to drive an ‘‘epithelial
escalator’’ that expels intestinal parasites (Cliffe et al., 2005).
NF-kB, a master regulator of inflammatory response genes,
functions in basal states to ensure continuous epithelial replace-
ment and barrier integrity; under select inflammatory conditions,
as in Trichuris (whipworm) infection in mice (Cliffe et al., 2005),
inflammatory mediators can accelerate epithelial replacement
as a host defense mechanism. Mice with conditional knockout
of intestinal epithelial IkB kinase-g or both IKKa and IKKb lose
the capacity for NF-kB activation and develop severe chronic
intestinal inflammation (Nenci et al., 2007). Epithelial NF-kB defi-ciency results in reduced expression of antimicrobial peptides
and a heightened level of enterocyte apoptosis that outpaces
adaptive changes in epithelial renewal; the result is a breach in
the mucosal barrier and bacterial translocation (Nenci et al.,
2007).
In mouse models, increased intestinal permeability may pre-
cede the development of nonresolving intestinal inflammation
(Olson et al., 2006). Molecular defects in junctional complex
proteins, such as JAM-A (Laukoetter et al., 2007), or expression
of a constitutively active myosin light chain kinase result in
increased numbers of intestinal myeloid and T cells within the
mucosa and more severe colitis in chemically or T cell-induced
models of inflammatory bowel disease (IBD) (Su et al., 2009).
Whether tight junction abnormalities precede or follow inflam-
mation in IBD is controversial—less subtle mucosal breaches
(ulcers) occur frequently in colitis, as well (Schulzke et al.,
2009).
Goblet Cells: Mucus and Mucins
Mucus produced by goblet cells forms a key component of the
mucosal barrier. It is a rich and consistent source of nutrients
for saccharolytic bacterial members of the microbiota and
a microhabitat where microbiota can embed themselves in
close proximity to one another to express their nutrient sharing
(syntrophic) relationships, and to avoid wash out from the con-
tinuously perfused and peristaltic gut bioreactor. Gel-forming
mucins of intestinal mucus are arranged into a bilayer with
a firm inner layer devoid of bacteria and a looser outer layer
(Johansson et al., 2008). MUC2 is the most abundant mucin of
intestinal mucus. Mice harboring MUC2 missense mutations
develop chronic inflammation in their distal intestine, resembling
human ulcerative colitis (UC). Misassembly of mutant MUC2
multimers leads to stress conditions in the endoplasmic retic-
ulum (ER) and initiation of the unfolded protein response (UPR)
(Heazlewood et al., 2008). Goblet cell loss and mucodepletion
are frequent histopathologic features in human UC (Gersemann
et al., 2009). UC samples also show evidence of ER stress and
accumulation of MUC2 precursors (Heazlewood et al., 2008).
The interrelationship between themicrobiota and barrier function
is illustrated by the fact that the short-chain fatty acid (SCFA) end
products of microbial fermentation modulate expression of the
MUC2 gene: propionate directly increases MUC2 expression
(the gene contains SCFA-responsive regulatory elements),
whereas butyrate regulates expression via effects on histone
acetylation and methylation and interaction with an AP1 cis
element (Burger-van Paassen et al., 2009).
Paneth Cells: UPR and Autophagy Regulate Intestinal
Inflammation
Paneth cells play a critical role in host defense through their
production of zinc, lysozyme, and numerous other antimicrobial
molecules. Paneth cells actively sense the microbiota and
regulate their production of antimicrobial peptides via cell-
autonomous MyD88-dependent activation of Toll-like receptors
(TLRs), thereby limiting barrier breaches by commensal bacteria
and pathogens (Vaishnava et al., 2008). Several recent studies
have provided insight into the importance of this cell type for
intestinal homeostasis. The unfolded protein response (UPR)
and autophagy play key roles in regulating Paneth cell func-
tion. Genetic alteration of the unfolded protein response gene,Cell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc. 861
XBP1 (X-box binding protein 1), a transcription factor whose
activation increases protein quality control and ER expansion,
or hypomorphic expression of the autophagy gene, ATG16L1,
both perturb Paneth cell function. This has profound conse-
quences for a host’s ability to maintain a productive equilibrium
with its microbiota. XBP1 influences the antimicrobial activity
and number of Paneth cells. Loss of XBP decreased small intes-
tinal crypt lysozyme levels and decreased bactericidal activity
against Salmonella typhimurium in a crypt homogenate. XBP
also dampens the enterocyte response to proinflammatory
stimuli, such as flagellin and TNF-a, and its deletion results in
basal activation of c-Jun-N-terminal kinase and NF-kB, both of
which orchestrate proinflammatory programs (Kaser and Blum-
berg, 2009). There is a significant association between human
IBD and several hypomorphic XBP1 variants (rs35873774;
p value, 1.6 3 105), and mice with a conditional deletion of
XBP1 in intestinal epithelial cells develop spontaneous enteritis
(Kaser et al., 2008).
The UPR is activated by ER stress, and ER stress induces
autophagy. These two cellular homeostatic response mecha-
nisms both play an important role in regulating inflammation.
Genome-wide association studies (GWAS) have identified a
variant in the autophagy protein, ATG16L1, which confers
increased predisposition for Crohn’s disease (Hampe et al.,
2007; Rioux et al., 2007). Two recent studies in mice provide
insight into how this ATG16L1 T300A variant may contribute
to the multiple cellular defects intrinsic to Crohn’s disease.
In mice hypomorphic for Atg16L1 protein expression, Paneth
cells show striking defects in granule content and exocytosis
(Cadwell et al., 2008). Similar results from mice with engineered
deficiencies of ATG5 or ATG7 in the intestinal epithelium further
support the importance of autophagy for Paneth cell function
(Cadwell et al., 2008). The ATG16L1 Crohn’s disease variant
also inhibits autophagy of the enteric pathogen, Salmonella
typhimurium (Kuballa et al., 2008). In addition to the genetic
association of ATG16L1 with Crohn’s disease, another variant
of the autophagy protein, IRGM, has also been identified in asso-
ciation with Crohn’s disease (McCarroll et al., 2008).
Defensins: Cause or Effect of IBD
Compromised responses to ER stress and autophagy both
affect the ability of Paneth cells to secrete antimicrobial pep-
tides. Paneth cells, enterocytes, neutrophils, and plasma cells
of the colon can express antimicrobial molecules (C-type lectins,
defensins, and cathelicidins) that function in host defense and
shape a host’s microbial communities. The defensins are the
most widely and highly expressed antimicrobial peptides and
altered defensin levels may be a factor in the pathogenesis of
IBD (Ramasundara et al., 2009). Reduced Paneth cell alpha-
defensin and beta-defensin levels have been observed in
patients with ileal Crohn’s disease (Wehkamp et al., 2005) and
in Crohn’s disease involving the colon (Fellermann et al., 2006),
respectively. Both Wnt signaling and sensors of intracellular
peptidoglycan cooperatively regulate alpha-defensin expression
(Kobayashi et al., 2005; Wehkamp et al., 2007). A mutation in
NOD2 (the muramyl dipeptide recognition receptor) found in
a subset of Crohn’s disease patients exacerbates alpha-defen-
sin deficiency, and NOD2 regulates the expression of the
alpha-defensin Defcr-rs10 (Kobayashi et al., 2005). Reduced862 Cell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc.expression of Tcf-4 (Wnt pathway) in ileal tissues of Crohn’s
disease patients with ileal involvement correlates with reduced
expression levels of the alpha-defensins HD5 and HD6 (Weh-
kamp et al., 2007).
Members of the RegIII family of C-type lectins that bind to
peptidoglycan are expressed in Paneth cells, as well as absorp-
tive enterocytes, and are bactericidal. Reg IIIg/HIP-PAP expres-
sion is dependent on the microbiota (Cash et al., 2006) and tran-
scriptionally regulated by MyD88-dependent signals, and the
polypeptides are posttranslationally activated by proteolytic
processing (Mukherjee et al., 2009). RegIIIg also is regulated
by a subset of NK1.1+ intestinal cells that secrete IL-22 (Sanos
et al., 2009). Reg IIIg /HIP-PAP protects the host from foodborne
enteropathogens such as Listeria (Brandl et al., 2007; Sanos
et al., 2009). How modulation of alpha- and/or beta-defensin or
C-type lectin levels affects a host’s gut microbial community
structure and affects IBD pathogenesis is and needs to be
explored with metagenomic methods (Salzman et al., 2010).
Gnotobiotic mouse models with inducible knockout of genes
encoding using antimicrobial agents, colonized with various
types of microbial communities, should help address these
questions.
Inflammatory Bowel Disease: Immunodeficiency
or Hyperimmunity
UPR and autophagy defects in Crohn’s disease raise questions
about whether pathophysiology is rooted in immunodeficiency
or dysregulated inflammation. The Paneth cell defects observed
in XBP1-deficient mice and the role of autophagy in both Paneth
cells and in eliminating intracellular bacteria suggest immunode-
ficiency (Coulombe and Behr, 2009). Elevated JNK and NF-kB
levels observed in the epithelium of mice with impaired ER stress
responses (Kaser et al., 2008) and the high levels of active IL-1b
and IL-18 in macrophages expressing Atg16L1 T300A suggest
a hyperactive or dysregulated inflammatory state (Saitoh et al.,
2008).
Under certain circumstances, the adaptive immune system
appears to compensate for immunodeficiencies such as loss
of certain innate immune safeguards. Deficiency in MyD88
and/or TRIF (adaptors for the toll-like receptors) results in innate
immune defects in sensing of the intestinal microbiota. Nonethe-
less, these mice are viable and do not develop spontaneous
intestinal inflammation when raised under specified pathogen-
free (SPF) conditions (Rakoff-Nahoum and Medzhitov 2008).
However, when mature B cell and immunoglobulin responses
are crippled by deletion of the JH gene in conjunction with
MyD88 deficiency, mice cannot coexist with their microbiota
(Slack et al., 2009). T-bet/ RAG2/mice, which lack adaptive
immune cells (T cells, B cells, and natural killer T cells), develop
a MyD88-independent ulcerative colitis driven by dendritic cell
TNF-a overproduction in response to the microbiota (Garrett
et al., 2007, 2009). Adoptive transfer of T-regulatory cells amelio-
rates this colitis, compensating for defects in the innate immune
system that are present in T-bet/ RAG2/ mice and may
explain why T-bet-deficient mice have no evidence of colitis
(Garrett et al., 2007).
There is a well-recognized increased frequency of autoim-
mune disorders in patients with immunodeficiency diseases:
complement system deficiencies (system lupus erythematosis),
common variable immunodeficiency (hemolytic anemia,
rheumatoid arthritis, and thyroiditis), and T-regulatory cell abnor-
malities/Foxp3mutations (X-linked IPEX syndrome [immunodys-
regulation, polyendocrinopathy, and enteropathy]). Certain host
genetic alterations resulting in immunodeficiency may lead to
changes in core features or in membership structure of microbial
communities. The pathophysiology of IBD undoubtedly reflects
a triad of immunodeficiency, altered microbial communities,
and hyperimmunity.
M Cells and Enteroendocrine Cells
Both M cells and enteroendocrine cells function as important
sensors of intestinal luminal contents. M cells (microfold cells)
are present in the small intestine overlying Peyer’s patches
(PP) and lymphoid follicles; they lack microvilli and the thick gly-
cocalyx present on enterocytes and are adept at transcytosis.
M cells express toll-like receptors, a5b1 integrin, and galectin-
9 on their apical surfaces, all of which facilitate M cell sensing
and transport of microbes (Kyd and Cripps, 2008). Various tech-
nical hurdles have stymied a comprehensive understanding of
their functioning as sensors and details of how they relay signals
to the lymphoid structures with which they interdigitate and over-
lie. Their importance as entry portals for a variety of infectious
organisms, including prions, viruses, and pathogenic bacteria,
and as targeted delivery sites for vaccine antigens is well recog-
nized (Corr et al., 2008). Enteroendocrine cells are strategically
positioned to sense luminal signals, including the products of
microbial metabolism, and to transduce these signals to adja-
cent, underlying, and/or remote cell populations through secre-
tion of various bioactive products (e.g., factors that regulate
mucus secretion, modulate aspects of host energy metabolism,
and regulate intestinal motility). Alterations in enteroendocrine
populations are seen in mouse models of enteritis and colitis
(Linden et al., 2005; O’Hara et al., 2006; Rubin et al., 2000) and
in patients with IBD (El-Salhy et al., 1997). Although these asso-
ciations may be casual rather than causal, enteroendocrine cells
express toll-like receptors (TLRs) (Bogunovic et al., 2007), and
gene expression profiling of a human enteroendocrine cell line
in response to dietary and microbial stimuli suggests that they
may directly participate in host inflammatory responses by
secreting cytokines and chemokines (Palazzo et al., 2007).
A Relationship Map of Cell-Cell Regulation in the Gut
The inflammatory response is a ‘‘robust’’ system, one that (1)
responds to environmental change, (2) is regulated by nega-
tive-feedback and feed-forward controls, and (3) is modular
(consisting of insulated subsystems so that failure does not
spread from one module to another) (Kitano, 2002). The pres-
ence of both adaptive and innate components provides the
immune system with system safeguards as does the anatomy
of the intestine at both the tissue and cellular level. At the tissue
level, barriers limit exposure and promote a degree of ‘‘unaware-
ness’’ (Hooper, 2009). At the cellular level, intestinal epithelial
cells, myofibroblasts, stromal cells, T cells, B cells, myeloid cells,
and the microbiota all participate in a network of interactions
regulating the inflammatory tone of the intestine. While the
cellular players continue to be characterized at ever-increasing
levels of refinement andmany key effector molecules are known,
there are still huge gaps in our understanding of how immune cellbehaviors are achieved. Many outstanding recent reviews have
focused on the function of specific cell types at mucosal inter-
faces (DCs: Rescigno and Di Sabatino, 2009; Strober, 2009;
macrophages: Platt and Mowat, 2008; T cells: van Wijk and
Cheroutre, 2009; T-regulatory cells: Barnes and Powrie, 2009;
Belkaid and Tarbell, 2009; Izcue et al., 2009; Th17 cells: Korn
et al., 2009; and innate T cells: Meresse and Cerf-Bensussan,
2009). T-regulatory cells and the Th17 subset of CD4+ T cells
are reviewed in this issue (see Review by D.R. Littman and A.Y.
Rudensky on page 845). Here, we focus on the sensing, sensor,
and sensor signaling regulation of intestinal myeloid cells and
briefly consider the recently recognized role of intestinal stromal
cells and lymph node stromal cells in intestinal homeostasis and
peripheral tolerance, respectively.
Stromal Cells
Intestinal stromal cells, distinct from myofibroblasts, play a crit-
ical role in tissue regeneration and wound repair and communi-
cate both with the overlying epithelium and immune cells (Stap-
penbeck and Miyoshi, 2009). MyD88-dependent signals control
the mesenchymal positioning of COX-2-expressing stromal cells
necessary to maintain appropriate epithelial proliferation in
response to injury (Brown et al., 2007). Intestinal stromal cells
constitutively express COX-2 and produce prostaglandins
[PGE(2) in a COX-2 dependent fashion; this basal prostaglandin
production may shape the basal cytokine profiles of the intes-
tine; Newberry et al., 1999, 2001]. Caspase-1 activation in intes-
tinal stromal cells appears to be an important mechanism by
which Salmonella typhimurium initiates inflammation; this
stromal cell-initiated inflammation was protective as caspase-
1-deficient mice develop disseminated infection (Mu¨ller et al.,
2009).
Lymph node stromal cells (LNSCs) have recently emerged as
key effectors in the regulation of CD8+, but not CD4+, T cell
peripheral tolerance to intestinal self-antigens (Lee et al., 2007;
Magnusson et al., 2008). CD45-UEA-I+ LNSCs express Aire,
a transcription factor and proapoptotic factor first identified in
the thymus that regulates the ectopic expression of peripheral
tissue antigens (Lee et al., 2007; Mathis and Benoist, 2009;
Gardner et al., 2009). While self-antigens have been detected
in LNSCs (Lee et al., 2007; Nichols et al., 2007), the role of LNSCs
in tolerance to microbial epitopes is unknown. Numerous
viruses, parasites (Leishmania and Plasmodium), and prions
have been shown to target LNSCs (Mueller and Germain,
2009). Whether and/or how the microbiota shapes stromal cell
representation or positioning within mesenteric and peripheral
lymph nodes remains to be determined. How inflammation
affects LNSC function, if at all, needs to be explored, as well.
Clearly, many questions remain about LNSC function in the
induction and maintenance of tolerance (reviewed in Reynoso
et al., 2009).
Dendritic Cells and Macrophages
The myeloid lineage’s monophagocytic cells include both den-
dritic cell (DC) and macrophage populations. DCs are described
as the preeminent antigen-processing and -presenting cell of
the immune system, with the unique ability to activate both
naive and memory T cells (Steinman, 2007). This definition has
stood the test of time, as the diversity and capabilities of DCs
continue to unfold. DCs have been categorized into differentCell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc. 863
subsets on the basis of their functional properties and their
integrin and chemokine receptor expression (Coombes and
Powrie, 2008). While DCs may develop from a number of distinct
precursors, most DCs go through distinct maturation stages and
are shaped by the local conditions of the tissues in which they
reside or migrate through. There are two principal subsets of
DCs: plasmacytoid (pDCs) and conventional myeloid (cDCs).
Key features of pDCs are their expression of toll-like receptor
7, which binds single-stranded RNA in endosomes, and toll-
like receptor 9, which binds unmethylated CpG, as well as their
production of type 1 interferons. Both pDCs and cDCs localize
to intestinal immune inductive and effector sites. The microbiota
in combination with CD8+ T cells cooperate to regulate systemic
numbers of pDCs on the basis of the observations that (1)
‘‘restricted flora’’ (RF) mice have reduced pDCs numbers
compared to SPF and GF animals and (2) deletion of CD8 or
perforin in RF and SPF mice increases pDCs numbers (Fujiwara
et al., 2008). Comparisons of wild-type SPF and GF, and SPF
MyD88/ TRIF/ mice disclosed that the proportion and
pattern of maturation marker expression of resident and migra-
tory cDCs in lymphoid organs were quite similar; this result
was to some extent unexpected, as many TLR ligands are
regarded as classical activators of DC maturation programs
(Wilson et al., 2008). cDCs may very well have cell-autonomous
migration patterns, and it is known that a panoply of nonmicro-
bial stimuli can induce their maturation programs—for example,
tissue damage or disruption of E-cadherin-mediated adhesion
(Jiang et al., 2007). In certain models and tissues, DC distribution
does appear to be influenced by themicrobiota, as DCs have not
been detected in the jejunum of GF pigs (Haverson et al 2007).
Intestinal DCs promote lymphocyte lineage responses that
both foster coexistence with the intestinal microbiota and erad-
icate pathogenic organisms. They also influence the trafficking of
lymphocytes in the gut by modulating integrin expression critical
for intestinal homing. DCs are a nexus for linking innate and
adaptive immunity and as such a central cellular node for regu-
lation of the inflammatory response.
Myeloid Cell Sensing
Sensing of intestinal contents occurs constitutively in myeloid
cells. DCs directly sense intestinal contents by extending their
dendritic processes into the lumen—a carefully orchestrated
cell biological feat requiring a dynamic cytoskeleton and expres-
sion of integrins and junctional proteins (Niess et al., 2005;
Rescigno et al., 2001). DCs and macrophages ‘‘telesense’’
through epithelial intermediaries. In the subepithelial dome of
PPs, they encounter luminal contents transcytosed by M cells.
DCs and macrophages internalize not only partially degraded
luminal products from absorptive enterocytes but also fragments
of apoptotic epithelial cells (Huang et al., 2000). The human
neonatal Fc receptor can also transport IgG/antigen complexes
from the lumen across the barrier to DCs (Yoshida et al., 2004).
Many of these receptors recognize microbe-associated molec-
ular patterns, as is the case for TLRs (see Review by S. Akira
et al. on page 805 of this issue), nucleotide-binding oligomeriza-
tion-domain protein-like receptors (NLRs), and C-type lectin
receptors, while others bind antibodies or eukaryotic cells or
their components. Myeloid cells express several receptors that
confer responsiveness to the classic mediators of inflammation,864 Cell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc.including vasoactive amines, complement components, vasoac-
tive peptides, and lipid mediators (Medzhitov, 2008). They also
express cytokine and chemokine receptors to gauge the inflam-
matory tone of the mucosal barrier and tune responses received
via other receptors.
Cellular and Subcellular Sensing Regulation
How is microbial sensing regulated at the cellular level in den-
dritic cells and macrophages? While different cellular subsets
express distinct receptors, this simple statement belies the
complexity intrinsic to what subsets express which receptors
at certain levels. What transcriptional networks, posttranscrip-
tional processing systems, and subcellular receptor targeting/
localization mechanisms are responsible? Some intestinal mye-
loid populations under basal conditions examined ex vivo
appear to be hyporesponsive to microbe-associated molecular
patterns compared to their counterparts isolated from lymphoid
tissues. Does receptor expression alone result in this hypores-
ponsiveness? Pulsatile and prolonged exposure of bone
marrow-derived macrophages to LPS in vitro fails to elicit
sustained proinflammatory cytokine expression, resulting in
what is termed ‘‘macrophage LPS tolerance’’ (West and Heagy,
2002). Chromatin modifications regulate hyporesponsiveness.
Certain proinflammatory TLR-induced genes have been shown
to acquire specific chromatin modifications resulting in transient
silencing, while other sets of genes with direct microbicidal
properties appear upregulated (Foster et al., 2007). Such
epigenetic mechanisms provide an essential level of regulation
for inflammatory responses (see Review by S.T. Smale on
page 833 of this issue). The kinase Akt1 also contributes to regu-
lation of LPS tolerance via its positive and negative regulation of
four microRNAs which in turn regulate TLR4 expression and
expression of the transcription repressor SOCS1 (Androulidaki
et al., 2009). Ligation of TLRs, proinflammatory cytokine recep-
tors and purinergic receptors (Atarashi et al., 2008) would all
seem to initiate signaling cascades that converge on master-
regulator transcriptional factors that drive inflammatory host
defense programs. However, epigenetic mechanisms appear
to play a profound role in the kinetics and shape of the response
that ensues.
Immunologic memory is a feature of both T and B lymphoid
cells, and the concept of macrophage LPS tolerance suggests
that innate immune subsets may have a kind of memory as
well. A host’s immunologic history, its food antigens, viral, and
microbial exposures may all impact on the behavior of its
sensors. How this information is stored (chromatin modification)
or passed on beyond the lifetime of single cells (if at all) needs to
be determined.
Sensor Stimuli Regulation and Inflammatory Stimuli
Another layer of regulation focuses on what is sensed. LPS, the
TLR4 ligand, is the classic activator of the maturation program,
which refashions DCs from sentinels to activators of naive
T cells. The gut epithelium may have the ability to inactivate
certain TLR ligands. For example, in zebrafish, intestinal alkaline
phosphatase at the epithelial brush border dephosphorylates the
lipid A moiety of LPS, which efficiently detoxifies endotoxin
(Bates et al., 2007). In many Bacteroides species (common
members of the mammalian distal gut microbiota; Ley et al.,
2008), the lipid A substituent of LPS lacks a 2-hydroxyl-myristoyl
moiety (C14:2OH), making it a weak endotoxin that is not very
immunostimulatory (Hofstad et al., 1993). Perhaps there was
selective pressure for nonstimulatory LPS, as basal not chronic
activated immunity in the intestine would likely provide a more
suitable/sustainable habitat.
Simultaneous engagement of multiple TLRs by products from
microbial communities or an invasive pathogen may vary signal
strength. TLR9 binding of DNA derived from themicrobiota plays
an important role in balancing T regulatory and T effector cell
immune responses and in host defense for Encephalitozoon
cuniculi, a microsporidian parasite that causes diarrheal, res-
piratory, and neurological diseases in immunocompromised
humans (Hall et al., 2008). Another example comes from the
observation that components of a host’s microbiota sensed
through TLR 2, 4, and 9 triggers protective T cell responses to
oral infection with Toxoplasma gondii (Benson et al., 2009).
TLRs and NLRs may also cross-regulate to maintain basal
states in the intestine. Binding of muramyl dipeptide (MDP) to
its intracellular receptor, NOD2, negatively regulates cytokine
responses initiated by multiple TLRs, and in vitro studies of
MDP-pretreated DCs suggest that enhanced IRF4 activity may
account for the TLR signal dampening that is observed (Wata-
nabe et al., 2008). As noted above, a subset of Crohn’s disease
patients bears NOD2 mutations, and inadequately damped TLR
signaling resulting from altered NOD2 function may contribute to
an increased susceptibility to IBD.
While both mutualists/commensals, and pathogens share
many similar microbe-associated molecular patterns (MAMPs),
there are of course numerous pathogenic microbe-specific
molecules or virulence factors—adhesive and invasive mole-
cules, toxins, and proteases—that can either alter MAMP levels
or trigger inflammation (Sansonetti and Medzhitov, 2009). Intes-
tinal cells also appear to respond to the quorum-sensing mole-
cules that bacteria use for their communication. In vitro data
suggest that bacterial quorum-sensing molecules, such as
N-(3-oxododecanoyl)-L-homoserine lactone and Pseudomonas
quinolone signal (PQS, 2-heptyl-2-hydroxy-4-quinolone), may
participate in tuning DC programs regulating T cell effector func-
tion—for example, by driving DC IL-12 production (Skindersoe
et al., 2009). Bacteroides fragilis, a member of the normal human
gut microbiota, expresses a number of capsular polysaccha-
rides, including one with profound immunomodulatory func-
tions called polysaccharide A (PSA) that in mouse models of
colitis lowers the proinflammatory cytokines IL-23 and IL-17
and increases levels of the anti-inflammatory cytokine IL-10
(Mazmanian et al., 2008). In summary, stimuli for intestinal
immune sensors are broad and include nucleotides, MAMPs,
bacterial polysaccharides, and even bacterial quorum-sensing
molecules; undoubtedly, more stimuli and their sensors will be
uncovered.
Sensor and Signal Transduction Pathway Regulation
Signal integration, calibration by negative and positive modula-
tors, and cross-coupling networks regulate the set points for
basal and inflammatory responses downstream of sensors.
Studies of NF-kB regulation and TLR signaling have defined
many elements of the signaling network map of host and micro-
bial interaction, but much territory remains uncharted.TLR signaling is negatively regulated by at least four general
mechanisms: (1) subcellular localization (reviewed in Barton
and Kagan, 2009), (2) degradation, (3) deubiquitination, and (4)
competition (reviewed in Wang et al., 2009). A few of these regu-
lators have an established role in controlling intestinal inflamma-
tion in mouse models, while others have yet to be explored.
SOCS-1, via its SH3 domain, binds and polyubiquitinates Mal
(MyD88 adaptor-like protein), which is necessary for TLR2 and
TLR4 signaling. Mice deficient in SOCS1 (except for expression
in T and B cells) develop a fulminant colitis (Hanada et al., 2006).
A20, first identified as a critical negative regulator of TNF-
induced NF-kB activation, is also a key regulator of TLR-induced
NF-kB activity (Boone et al., 2004). A20-deficient mice display
severe systemic inflammation with extensive intestinal involve-
ment (Lee et al., 2000). While A20 possess both deubiquitination
and E3 ligase activity, its debuquitination of TRAF6 (a TLR
downstream effector) is what restricts TLR signaling. A20 inde-
pendently regulates both NLR signaling and TLR signaling.
Both in vitro and in vivo, A20 deficiency results in exaggerated
MDP responses, increased RIP2 ubiquitylation, and prolonged
NF-kB activation (Hitotsumatsu et al., 2008).
Other TLR negative regulators not fitting into the aforemen-
tioned categories include SIGIRR and the transcription factors
aryl hydrocarbon receptor and ATF3. SIGIRR (also known as
TIR8) exerts its inhibitory activity by trapping TRAF6 and IRAK1
(Wald et al., 2003). SIGIRR is highly expressed in intestinal
epithelial cells and DCs: mice with genetically engineered SI-
GIRR deficiency exhibit increased intestinal inflammation in the
dextran sulfate sodium (DSS) model of colitis (Garlanda et al.,
2007). The aryl hydrocarbon receptor is a basic helix-loop-helix
transcription factor that negatively regulates TLR4 signaling by
complexing with Stat1 and NF-kB, subsequently inhibiting tran-
scription of IL-6 (Kimura et al., 2009). Two recent studies have
mapped the inflammatory response regulatory networks in
innate immune cells. In macrophages, a three-component circuit
consisting of an initiator, amplifier, and attenuator (NF-kB,
C/EBPd, and ATF3, respectively) discriminates between tran-
sient and persistent TLR4 signals (Litvak et al., 2009). Intestinal
myeloid cells must distinguish between commensal/mutualist-
derived and pathogen-derived signals, and the feed forward
type 1 regulation described in Litvak et al. (2009) elucidates
how this process may be accomplished. Another laboratory
useda combination of gene expression profiling and short hairpin
RNAgene knockdown inDCs to construct a networkmodel ofDC
transcriptional responses to TLR2, 4, 5, and 9 agonists (Amit
et al., 2009). This landmark analysis of DC-pathogen responses
provides substantial mechanistic insight into how DCs achieve
specific responses to diverse pathogens through a combination
of core regulatory elements and fine tuners. Furthermore, the
experimental approach, which coupled ‘‘observation’’ with
‘‘targeted perturbations,’’ establishes a framework that is broadly
applicable for many biological systems.
Extraintestinal Effects of the Gut Microbiota
and Autoimmunity
The impact of the gut microbiota on health and disease extends
beyond the gastrointestinal tract. There is a growing apprecia-
tion for the contribution of microbes to allergic and autoimmuneCell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc. 865
diseases. For example, a randomized, double-blind, placebo-
controlled trial reported that treatment of infants with prebiotics
and probiotics reduced the cumulative incidence of atopic
eczema, although no characterization of microbial intestinal
communities was performed (Kukkonen et al., 2007). The vari-
able penetrance of diabetes in nonobese diabetic (NOD) mice
in different animal housing facilities has been ascribed to differ-
ences in environmental microbes. A recent study suggests that
the interactions between the innate immune system and intes-
tinal microbes are a key disease-modifying factor in the develop-
ment of type 1 diabetes (T1D) (Wen et al., 2008). Wen et al. found
that while MyD88-deficient NOD mice raised under SPF condi-
tions were protected from T1D, germ-free MyD88-deficient
NOD mice were not. Moreover, MyD88 deficiency altered the
lineage composition of the gut microbiota, and this altered
microbiota afforded some protection from diabetes when trans-
planted into germ-free NOD recipients. Increasingly, alterations
in the intestinal microbiota are being linked to obesity, asthma,
diabetes, IBD, and other inflammatory conditions, although, as
noted below, much additional work is needed in this area,
including assessments of the degree to which emerging associ-
ations are causally or casually related to pathogenesis.
Future Directions
Next-generation sequencing technology has placed mucosal
immunologists and microbiologists on a pathway of discovery
that should provide new insights about how microbial communi-
ties assemble during postnatal life, how their organismal and
genetic composition vary during the various stages of the human
life cycle, and how their dynamic operations are shaped by and
in turn shape the innate and adaptive immune systems.
Gnotobiotic mice representing both wild-type inbred strains
and genetically engineered derivatives provide an opportunity
to address a number of issues that cannot be readily examined
in humans at the present time. Results from such analyses
should help formulate hypotheses and concepts about the
microbiota-immune interface that can then be tested in a more
directed manner in humans. For example, the physical organiza-
tion of the gut microbiota could be characterized over varying
spatial scales (Camp et al., 2009), along the length and width
of the gut, and under conditions where confounding variables
in humans, such as diet (a major factor determining variations
in microbial community structure in the gut) (Ley et al., 2008),
and host genotype, can be constrained.Multicolored fluorescent
in situ hybridization (FISH; for microbial visualization) and the
large collections of available antibodies and lectins (for charac-
terizing distinct immune subsets, stromal cells, and other
components of the mucosal barrier) could be used in concert
to decipher the physical interactions between members of the
microbiota and host. This effort could involve gnotobiotic mice
harboring model ‘‘synthetic’’ human gut microbiomes: i.e.,
communities of varying phylogenetic complexity, composed of
sequenced and cultured members of the human gut microbiota,
whose predicted genomes, proteomes, and metabolic activities
are available. Since transparent zebrafish can now be reared
under germ-free conditions and the response of germ-free ze-
brafish to colonization with a zebrafish (or mouse) gut microbiota
is very analogous to that noted in mice (Rawls et al., 2006),866 Cell 140, 859–870, March 19, 2010 ª2010 Elsevier Inc.simplified microbial communities that contain members engi-
neered to express fluorescent proteins could be constructed
(e.g., see Rawls et al., 2007) and introduced into germ-free ze-
brafish engineered to contain immune cell subsets expressing
distinct fluorescent proteins (Kanther and Rawls, 2010). The
union of these methods could yield a model system that enables
real time imaging of dynamic interactions betweenmicrobes, the
host’s immune system, and other components intimately associ-
ated with or physically remote from the gut mucosal barrier.
Comparative metagenomic analyses are currently being con-
ducted in patients with IBD and in suitable control populations.
These analyses include 16S ribosomal RNA gene-based surveys
of their gut microbiota (to determine who is there), shotgun
sequencing of their gutmicrobiomes (to characterize what genes
and predicted pathways are present), characterization of their
gut communities’ metatranscriptomes and metaproteomes (to
delineate which microbial genes are expressed; Verberkmoes
et al., 2009), and in some cases, targeted or shotgun NMR-
and mass spectrometry-based characterization of their gut
microbial communities’ metabolomes. Reference control popu-
lations in these studies can consist of the individuals themselves
during relapses and remissions or family members such as
discordant monozygotic cotwins with andwithout disease. Inter-
preting these vast data sets and developing hypotheses about
host-microbial interactions will undoubtedly be very challenging.
Such analyses should enlighten our vision of inputs or stimuli for
the immune system. Bacterial metabolites and their recognition
by innate immune and epithelial cells may represent new compo-
nents of circuits that modulate inflammatory responses in the
intestine.
Experimentally, combining gnotobiotics and metagenomics
will allow for evaluation of immunoregulatory functions of com-
plex microbial communities. Gut communities from individuals
can be directly transferred to germ-free mice (Turnbaugh et al.,
2009b): recipient mice could be genetically engineered so
that they are sensitized for development of immunopathology
because they harbor the very mutations that are also found in
humans with IBD. Potentially confounding variables encoun-
tered in studies of humans, such as diet and host genotype,
could be constrained through the use of these ‘‘humanized’’
gnotobiotic animals. Other host phenotypes have been trans-
ferred via microbiota transplantation (e.g., Bowey et al., 2003;
Turnbaugh et al., 2006, 2008). One hope from these types of
experiments would be to operationally define gut microbial
communities that promote or suppress inflammatory states: in
this sense, they could become integral parts of clinical studies
as well as a platform for fulfilling Koch’s postulates where the
causative ‘‘microbe’’ is a microbiota rather than a single path-
ogen. Finally, recent advances in successful engraftment of the
human adaptive and innate immune systems into mice offer
the tantalizing possibility of recreating a more fully humanized
intestinal ecosystem populated by human immune cells and
a human microbiota in gnotobiotic animals.ACKNOWLEDGMENTS
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